Friday, July 31, 2026

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

Exploring North Korea’s Healthcare Revolution: The Role of the New Pyongyang General Hospital in 2026

North Korea appointed Jeong Geum-cheol as director of the Pyongyang General Hospital, emphasizing public welfare and healthcare expansion.

Tag: social service agent

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.